Home > > > Report Detail

Global Anti-Infectives Market Research Report 2024

Publisher Name :
Date: 10-Jan-2024
No. of pages: 78
Inquire Before Buying

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and The rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, The industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in The market and ensure their products reach patients in need. Additionally, The COVID-19 pandemic has highlighted The importance of vaccine development and supply chain management, further emphasizing The need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of The global market for Anti-Infectives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess The market competitive situation, analyze their position in The current marketplace, and make informed business decisions regarding Anti-Infectives.

Report Scope

The Anti-Infectives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as The base year, with history and forecast data for The period from 2019 to 2030. This report segments The global Anti-Infectives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of The market, The report provides profiles of The competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help The Anti-Infectives manufacturers, new entrants, and industry chain related companies in this market with information on The revenues, sales volume, and average price for The overall market and The sub-segments across The different segments, By Company, by Type, by Application, and By Regions.

Market Segmentation

By Company

- Astra Zeneca plc

- Johnson & Johnson

- Glaxo SmithKline plc

- Novartis

- Pfizer

- Wockhardt ltd

- Roche

- Sanofi

- Merck

Segment by Type

- Antibacterial

- Antiviral

- Antifungal

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Mail Order Pharmacies

Consumption By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Chapter Outline

Chapter 1: Introduces The Report Scope of The report, executive summary of different market segments (

By Region, by Type, by Application, etc), including The market size of each market segment, future development potential, and so on. It offers a high-level view of The current state of The market and its likely evolution in The short to mid-term, and long term.

Chapter 2: Detailed analysis of Anti-Infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Anti-Infectives in regional level and country level. It provides a quantitative analysis of The market size and development potential of each region and its main countries and introduces The market development, future development prospects, market space, and market size of each country in The world.

Chapter 4: Provides The analysis of various market segments by Type, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different market segments.

Chapter 5: Provides The analysis of various market segments by Application, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing The basic situation of The main companies in The market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including The upstream and downstream of The industry.

Chapter 8: Introduces The market dynamics, latest developments of The market, The driving factors and restrictive factors of The market, The challenges and risks faced by manufacturers in The industry, and The analysis of relevant policies in The industry.

Chapter 9: The main points and conclusions of The report.

Global Anti-Infectives Market Research Report 2024

Table of Contents
1 Anti-Infectives Market Overview
1.1 Product Overview and Scope of Anti-Infectives
1.2 Anti-Infectives Segment by Type
1.2.1 Global Anti-Infectives Market Value Comparison by Type (2024-2030)
1.2.2 Antibacterial
1.2.3 Antiviral
1.2.4 Antifungal
1.3 Anti-Infectives Segment by Application
1.3.1 Global Anti-Infectives Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Mail Order Pharmacies
1.4 Global Anti-Infectives Market Size Estimates and Forecasts
1.4.1 Global Anti-Infectives Revenue 2019-2030
1.4.2 Global Anti-Infectives Sales 2019-2030
1.4.3 Global Anti-Infectives Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Infectives Market Competition by Manufacturers
2.1 Global Anti-Infectives Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Infectives Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Infectives Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Infectives Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Infectives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Infectives, Product Type & Application
2.7 Anti-Infectives Market Competitive Situation and Trends
2.7.1 Anti-Infectives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Infectives Players Market Share by Revenue
2.7.3 Global Anti-Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Infectives Retrospective Market Scenario by Region
3.1 Global Anti-Infectives Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Infectives Global Anti-Infectives Sales by Region: 2019-2030
3.2.1 Global Anti-Infectives Sales by Region: 2019-2024
3.2.2 Global Anti-Infectives Sales by Region: 2025-2030
3.3 Global Anti-Infectives Global Anti-Infectives Revenue by Region: 2019-2030
3.3.1 Global Anti-Infectives Revenue by Region: 2019-2024
3.3.2 Global Anti-Infectives Revenue by Region: 2025-2030
3.4 North America Anti-Infectives Market Facts & Figures by Country
3.4.1 North America Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Infectives Sales by Country (2019-2030)
3.4.3 North America Anti-Infectives Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Infectives Market Facts & Figures by Country
3.5.1 Europe Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Infectives Sales by Country (2019-2030)
3.5.3 Europe Anti-Infectives Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Infectives Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Infectives Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Infectives Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Infectives Market Facts & Figures by Country
3.7.1 Latin America Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Infectives Sales by Country (2019-2030)
3.7.3 Latin America Anti-Infectives Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Infectives Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Infectives Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Infectives Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Infectives Sales by Type (2019-2030)
4.1.1 Global Anti-Infectives Sales by Type (2019-2024)
4.1.2 Global Anti-Infectives Sales by Type (2025-2030)
4.1.3 Global Anti-Infectives Sales Market Share by Type (2019-2030)
4.2 Global Anti-Infectives Revenue by Type (2019-2030)
4.2.1 Global Anti-Infectives Revenue by Type (2019-2024)
4.2.2 Global Anti-Infectives Revenue by Type (2025-2030)
4.2.3 Global Anti-Infectives Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Infectives Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Infectives Sales by Application (2019-2030)
5.1.1 Global Anti-Infectives Sales by Application (2019-2024)
5.1.2 Global Anti-Infectives Sales by Application (2025-2030)
5.1.3 Global Anti-Infectives Sales Market Share by Application (2019-2030)
5.2 Global Anti-Infectives Revenue by Application (2019-2030)
5.2.1 Global Anti-Infectives Revenue by Application (2019-2024)
5.2.2 Global Anti-Infectives Revenue by Application (2025-2030)
5.2.3 Global Anti-Infectives Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Infectives Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astra Zeneca plc
6.1.1 Astra Zeneca plc Corporation Information
6.1.2 Astra Zeneca plc Description and Business Overview
6.1.3 Astra Zeneca plc Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astra Zeneca plc Anti-Infectives Product Portfolio
6.1.5 Astra Zeneca plc Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Anti-Infectives Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Glaxo SmithKline plc
6.3.1 Glaxo SmithKline plc Corporation Information
6.3.2 Glaxo SmithKline plc Description and Business Overview
6.3.3 Glaxo SmithKline plc Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glaxo SmithKline plc Anti-Infectives Product Portfolio
6.3.5 Glaxo SmithKline plc Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Anti-Infectives Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Anti-Infectives Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Wockhardt ltd
6.6.1 Wockhardt ltd Corporation Information
6.6.2 Wockhardt ltd Description and Business Overview
6.6.3 Wockhardt ltd Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wockhardt ltd Anti-Infectives Product Portfolio
6.6.5 Wockhardt ltd Recent Developments/Updates
6.7 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Anti-Infectives Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Anti-Infectives Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck Anti-Infectives Product Portfolio
6.9.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Infectives Industry Chain Analysis
7.2 Anti-Infectives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Infectives Production Mode & Process
7.4 Anti-Infectives Sales and Marketing
7.4.1 Anti-Infectives Sales Channels
7.4.2 Anti-Infectives Distributors
7.5 Anti-Infectives Customers
8 Anti-Infectives Market Dynamics
8.1 Anti-Infectives Industry Trends
8.2 Anti-Infectives Market Drivers
8.3 Anti-Infectives Market Challenges
8.4 Anti-Infectives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anti-Infectives Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-Infectives Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-Infectives Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-Infectives Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-Infectives Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-Infectives Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-Infectives Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-Infectives Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-Infectives, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Infectives, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Infectives, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Infectives, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Infectives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infectives as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Infectives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-Infectives Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-Infectives Sales Market Share by Region (2019-2024)
Table 19. Global Anti-Infectives Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-Infectives Sales Market Share by Region (2025-2030)
Table 21. Global Anti-Infectives Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-Infectives Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-Infectives Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-Infectives Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-Infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-Infectives Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-Infectives Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-Infectives Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-Infectives Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-Infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-Infectives Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-Infectives Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-Infectives Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-Infectives Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-Infectives Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-Infectives Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-Infectives Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-Infectives Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-Infectives Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-Infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-Infectives Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-Infectives Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-Infectives Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-Infectives Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-Infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-Infectives Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-Infectives Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-Infectives Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-Infectives Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-Infectives Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-Infectives Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-Infectives Sales Market Share by Type (2019-2024)
Table 53. Global Anti-Infectives Sales Market Share by Type (2025-2030)
Table 54. Global Anti-Infectives Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-Infectives Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-Infectives Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-Infectives Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-Infectives Price (USD/Unit) by Type (2019-2024)
Table 59. Global Anti-Infectives Price (USD/Unit) by Type (2025-2030)
Table 60. Global Anti-Infectives Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-Infectives Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-Infectives Sales Market Share by Application (2019-2024)
Table 63. Global Anti-Infectives Sales Market Share by Application (2025-2030)
Table 64. Global Anti-Infectives Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-Infectives Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-Infectives Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-Infectives Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-Infectives Price (USD/Unit) by Application (2019-2024)
Table 69. Global Anti-Infectives Price (USD/Unit) by Application (2025-2030)
Table 70. Astra Zeneca plc Corporation Information
Table 71. Astra Zeneca plc Description and Business Overview
Table 72. Astra Zeneca plc Anti-Infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Astra Zeneca plc Anti-Infectives Product
Table 74. Astra Zeneca plc Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Anti-Infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Johnson & Johnson Anti-Infectives Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Glaxo SmithKline plc Corporation Information
Table 81. Glaxo SmithKline plc Description and Business Overview
Table 82. Glaxo SmithKline plc Anti-Infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Glaxo SmithKline plc Anti-Infectives Product
Table 84. Glaxo SmithKline plc Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Anti-Infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Novartis Anti-Infectives Product
Table 89. Novartis Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Anti-Infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Anti-Infectives Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Wockhardt ltd Corporation Information
Table 96. Wockhardt ltd Description and Business Overview
Table 97. Wockhardt ltd Anti-Infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Wockhardt ltd Anti-Infectives Product
Table 99. Wockhardt ltd Recent Developments/Updates
Table 100. Roche Corporation Information
Table 101. Roche Description and Business Overview
Table 102. Roche Anti-Infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Roche Anti-Infectives Product
Table 104. Roche Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Anti-Infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Sanofi Anti-Infectives Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Anti-Infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Merck Anti-Infectives Product
Table 114. Merck Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Anti-Infectives Distributors List
Table 118. Anti-Infectives Customers List
Table 119. Anti-Infectives Market Trends
Table 120. Anti-Infectives Market Drivers
Table 121. Anti-Infectives Market Challenges
Table 122. Anti-Infectives Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Infectives
Figure 2. Global Anti-Infectives Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-Infectives Market Share by Type in 2023 & 2030
Figure 4. Antibacterial Product Picture
Figure 5. Antiviral Product Picture
Figure 6. Antifungal Product Picture
Figure 7. Global Anti-Infectives Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Anti-Infectives Market Share by Application in 2023 & 2030
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Mail Order Pharmacies
Figure 12. Global Anti-Infectives Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Anti-Infectives Market Size (2019-2030) & (US$ Million)
Figure 14. Global Anti-Infectives Sales (2019-2030) & (K Units)
Figure 15. Global Anti-Infectives Average Price (USD/Unit) & (2019-2030)
Figure 16. Anti-Infectives Report Years Considered
Figure 17. Anti-Infectives Sales Share by Manufacturers in 2023
Figure 18. Global Anti-Infectives Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Anti-Infectives Players: Market Share by Revenue in 2023
Figure 20. Anti-Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Anti-Infectives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Anti-Infectives Sales Market Share by Country (2019-2030)
Figure 23. North America Anti-Infectives Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Anti-Infectives Sales Market Share by Country (2019-2030)
Figure 27. Europe Anti-Infectives Revenue Market Share by Country (2019-2030)
Figure 28. Germany Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Anti-Infectives Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Anti-Infectives Revenue Market Share by Region (2019-2030)
Figure 35. China Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Anti-Infectives Sales Market Share by Country (2019-2030)
Figure 46. Latin America Anti-Infectives Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Anti-Infectives Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Anti-Infectives Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Anti-Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Anti-Infectives by Type (2019-2030)
Figure 56. Global Revenue Market Share of Anti-Infectives by Type (2019-2030)
Figure 57. Global Anti-Infectives Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Anti-Infectives by Application (2019-2030)
Figure 59. Global Revenue Market Share of Anti-Infectives by Application (2019-2030)
Figure 60. Global Anti-Infectives Price (USD/Unit) by Application (2019-2030)
Figure 61. Anti-Infectives Value Chain
Figure 62. Anti-Infectives Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs